We hereby submit Press Release for Q1FY27.

YH/SE/33/2026-27 August 10, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai - 400001, India Symbol: YATHARTH Scrip Code: 543950 ISIN: INE0JO301016 ISIN: INE0JO301016 Subject: Press Release Dear Sir/Ma’am, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release on the Financial Results of the Company for Q1FY27. The above Press Release will also be made available on the Company’s website: https://www.yatharthhospitals.com/investors/corporate-announcements This is for your kind information and records. Thanking You Your faithfully, For Yatharth Hospital & Trauma Care Services Limited Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166 Encl.: A/a Press Release For Immediate Release Yatharth Hospitals reports another quarter of stellar performance Revenue grew at record 51% YoY, while EBITDA grew at 39% YoY Faridabad Sector-20 achieves EBITDA breakeven in record nine months Board declares maiden interim dividend at 5% of Face Value Noida, August 10, 2026: Yatharth Hospital and Trauma Care Services Ltd (“the Company”) (NSE: YATHARTH, BSE:543950), a leading private super speciality hospital chains in North India, today announced its financial results for the quarter ending June 30, 2026. Financial Snapshot Particulars (Rs Mn) Q1FY27 Q1FY26 YoY (%) Q4FY26 QoQ (%) Revenue 3,927 2,592 51% 3,416 15% EBITDA 917 660 39% 799 15% EBITDA Margin1 23.3% 25.4% (209) bps 23.4% (5) bps Profit After Tax 454 420 8% 447 2% 1. Adjusted EBITDA Margin, excluding the impact of Faridabad Sector-20 and New Delhi stood at 28.1% Key Highlights • Revenue reaches at record Rs 3,927 mn, up 51% YoY and 15% QoQ ✓ New hospitals contribute Rs 1,067 Mn, 27% to Group revenue, led by strong ramp-up across Greater Faridabad, Model Town New Delhi, Faridabad Sector-20, and Agra ✓ Mature hospitals also sustained strong momentum, growing 22% YoY • Group ARPOB reaches Rs 34,758, up 7% YoY ✓ Premium NCR hospitals (Noida Extension and New Delhi) achieve Rs 50,000 mark in Q1 • EBITDA reaches at record Rs 917 Mn, up 39% YoY and 15% QoQ ✓ EBITDA margin (adjusted for ramp up losses) stood strong at 28.1% ✓ Acquisition playbook delivered early success - ✓ Faridabad Sector-20 achieves EBITDA breakeven in record nine month of operations ✓ Agra hospital delivers >20% EBITDA Margin, within first full quarter of integration • PAT stood at record Rs 454 mn, despite capacity additions ✓ Strong growth in Cash Profits (PAT plus depreciation) at 29% YoY, reflecting the underlying strength of the expanded network • Board declares maiden interim dividend at 5% of face value • Board approves ESOP grant under the ESOP Scheme 2024 and launch of new ESOP scheme 2026, aimed to attract, retain and align quality talent pool Commenting on the performance, Mr. Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “FY27 has commenced on a strong footing, marked by our strongest-ever quarterly revenue and EBITDA growth, while continuing to strengthen the scale and quality of our network. The performance reflects the successful execution of our growth strategy, with both mature and newly added hospitals contributing meaningfully during the quarter. Our newer facilities are progressing ahead of expectations, with Faridabad Sector-20 achieving EBITDA breakeven and Agra hospital contributing meaningfully to profits this quarter. Our premium NCR hospitals at Noida Extension and New Delhi have already approached the Rs 50,000 ARPOB mark, while Faridabad Sector-20 and the upcoming Gurugram hospital are expected to move towards similar benchmarks over time, validating our acquisition playbook, and our ability to unlock value across assets. In recognition of our healthy performance, the Board has approved our maiden interim dividend, balancing shareholder returns with continuing investments in growth.” Earnings Conference Call Tuesday, August 11, 2026 at 11:00 am IST Following the announcement of Q1FY27 results on August 10, 2026, the management of Yatharth Hospitals will host a conference call on August 11, 2026 at 11:00 am IST during which the management will discuss the performance and answer questions from the participants. Details of the call are given below: Conference Call Details Diamond Pass Link Link here +91 22 6280 1297 Universal Dial-In Numbers +91 22 7115 8198 Hong Kong: 800 964 448 Singapore: 8001012045 International Toll-Free Numbers UK: 08081011573 USA: 18667462133 About Yatharth Hospital & Trauma Care Services Ltd: Yatharth Hospital & Trauma Care Services Limited (Yatharth Hospitals) is one of North India’s leading healthcare providers, known for delivering high-quality medical care through a network of state-of-the-art super-speciality hospitals. The Group operates a robust network across key regions including Noida, Greater Noida, Noida Extension, Greater Faridabad, New Delhi, Gurugram and Jhansi-Orchha in Madhya Pradesh, with a growing presence in Agra. With over 2,500 beds across its expanding hospital network and an overall announced capacity of ~3,250 beds, Yatharth Hospitals has consistently strengthened its footprint through a combination of organic growth and strategic acquisitions, reinforcing its position as a fast-growing healthcare platform in North India. Disclaimer No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained is only current as of its date. Certain statements made may not be based on historical information or facts and may be “forward looking statements”, including those relating to the company’s general business plans and strategy, its future financial condition and growth prospects, and future developments in its industry and its competitive and regulatory environment. Actual results may differ materially from these forward-looking statements due to number of factors, including future changes or developments in the company’s business, its competitive environment, and political, economic, legal, and social conditions in India. Yatharth Hospital & Trauma Care Services Ltd (BSE: 543950, NSE: YATHARTH) For further information on the company, please visit https://www.yatharthhospitals.com Contact Information Corporate Office Mr. Ashutosh Kumar Jha Second Floor, Sovereign Capital Gate, FC-12 Sector 16A, Group Chief – Strategy, M&A and IR Noida, Gautam Buddha Nagar, 201301 investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706